10月8日，赛默飞世尔盘中下跌3.1%，报642.025美元/股，成交额5733.18万美元。消息面上，巴克莱银行此前将公司目标价从650美元大幅上调至750美元，重申跑赢大盘评级，但市场在股价前期连续走强后出现获利了结。
巴克莱此次上调目标价使市场平均目标价提升至658.76美元。与此同时，公司近期与Quantum BioPharma签署了多发性硬化症II期临床试验启动协议，临床研究业务扩张持续获得订单支撑。本次股价回落更贴近技术性调整，而非经营层面的负面信号。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.